Celyad Oncology
![Celyad Oncology](https://flanders.bio/storage/files/16b8231e-5008-4839-95ca-af70f392f83a/company_logo-member-celyad-oncology.jpg)
Rue Edouard Belin 12
1435 Mont-Saint-Guibert
BE
Celyad Oncology
Foundation date
24 July 2007
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Celyad Oncology is a biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.
Upcoming events
All events-
1109 '24
The Leuven Protein Aggregation Meeting (2nd edition)
Event by: VIB -
1010 '24
-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group
Latest news
More news-
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
Tuesday July 16th 2024
Read more
-
ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust
Tuesday July 16th 2024
Read more
-
Ghent University spin-off Trince wins Nature Spinoff Prize
Monday July 15th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator